Our Research Papers and Publications
Explore APAC Biotech’s groundbreaking research and contributions to the field of cancer immunotherapy. Our collection of peer-reviewed papers and publications highlights our commitment to advancing personalized cancer treatments, showcasing the science behind our innovative therapies. Stay informed about the latest findings and breakthroughs that drive our mission to transform cancer care.
Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN® (dendritic cell-based vaccine)
A retrospective analysis comparing APCEDEN® Dendritic Cell Immunotherapy with Best Supportive Care in refractory cancer
Immune modulation by dendritic-cell-based cancer vaccines
Single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care
Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy (APCEDEN®)
Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN® in combination with chemotherapy
Boosting Therapeutic Response By Outsmarting Tumor
Adjuvant based Immunotherapeutic Approaches to Enhance Patient Survival
APCEDEN® Protocol & Clinician Handbook
